Dyne Therapeutics Inc (NASDAQ:DYN)
| 11.46 Delayed Data As of 3:59pm ET |  -0.80 / -6.53%Today’s Change | 4.30 Today|||52-Week Range 17.89 | -3.62% Year-to-Date |
Latest DYN News | Press Releases
No recent news for Dyne Therapeutics Inc.
Today’s Trading
| Previous close | 12.26 |
| Today’s open | 12.03 |
| Day’s range | 11.44 - 12.26 |
| Volume | 9,154 |
| Average volume (3 months) | 188,517 |
| Market cap | $621.2M |
Data as of 3:59pm ET, 08/19/2022
Growth & Valuation
| Earnings growth (last year) | +28.95% |
| Earnings growth (this year) | -22.59% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.68 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | -$0.92 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$149.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
